Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... cells through direct interaction with LRP6; implications for the pathogenesis of diabetic nephropathy (Abstract #SA-PO2937)10The canonical Wnt signaling pathway involves a network of ...
2009 NOV 2 ... and technique survival were analyzed. Mean age at start of PD was 53 +/- 16 years; diabetic nephropathy was the main cause of chronic kidney disease. Cardiovascular disease was the main cause ...
2009 NOV 2 ... should be explored further as a potential antidiabetic remedy for the treatment of diabetic nephropathy." Kim and colleagues published their study in the Journal of Agricultural ...
2009 NOV 23 ... renal CXCL12 production to glomerular podocytes in db/db mice with early or advanced diabetic nephropathy. CXCL12 inhibition significantly reduced the degree of glomerulosclerosis, increased the ...
2009 NOV 1 ... will be developed for the treatment of complications of type 2 diabetes, preferentially diabetic nephropathy, but also others. The phase I study, conducted in the United Kingdom, was ...
2009 NOV 2 ... a patient illustrating this latter circumstance." "A 53-year-old man with diabetic nephropathy, with no known disease causing hypoxemia started HD in April 2001. Blood hemoglobin ...
2009 NOV 16 ... writing in the journal Clinical and Experimental Nephrology report. "Diabetic nephropathy has considerable impact on society in the areas of public health and social economy; ...
2009 NOV 9 ... not in beta-catenin-knockout littermates. In human proteinuric kidney diseases such as diabetic nephropathy and focal segmental glomerulosclerosis, we observed upregulation of Wnt1 and active ...
2009 NOV 1 ... Cardiovascular Diabetology report. "Decreased HSPG may contribute to diabetic endothelial injury. Decreased tissue HS in diabetes has been reported, however, ... of heparan sulfate (HS). Hyperglycemia in diabetes leads to endothelial injury and nephropathy, retinopathy and atherosclerosis," scientists writing in the journal Cardiovascular ...
2009 NOV 16 ... adiponectin is elevated in patients with chronic kidney disease (CKD), such as overt diabetic nephropathy." "The current study aimed to investigate whether anemia was ...
2009 NOV 23 ... renal tubular epithelial cells contributes to the renal fibrosis that is associated with diabetic nephropathy. Histone deacetylase (HDAC) determines the acetylation status of histones and thereby ...
2009 NOV 9 ... in expression of intact protein in the kidney, suggesting new potential mediators of diabetic nephropathy and candidate biomarkers for progressive renal function decline." Merchant ...
2009 NOV 9 ... to the observed therapeutic effects of sulodexide in microvascular vasculopathy such as diabetic nephropathy. These results also suggest that inhibition of TF activation of platelets by sulodexide ...
2009 NOV 1 ... risk factors reduces the rate of progression to end-stage renal failure in patients with diabetic nephropathy. The aim of our audit was to clarify whether improvements in patient care could be ...
2009 NOV 23 ... ml/min; P = 0.008) were significantly lower. Sixteen over 22 (73%) of the patients with diabetic nephropathy had MTHFR gene mutation, while this was only 27% (8 over 30) in normoalbuminuric ...
2009 NOV 16 ... altered glucose tolerance but, on the other hand, nephrotic syndrome associated with diabetic nephropathy made the diagnosis of beriberi heart disease difficult." Toyonaga and ...
2009 NOV 23 ... growth factor as well as the therapeutic efficacy of angiogenesis inhibitors in early diabetic nephropathy has been reported. Vasohibin-1 (VASH-1) is a unique endogenous angiogenesis inhibitor ...
